Advanced Endometrial Cancer Recruiting Phase 2 Trials for Envafolimab (DB15769)

IndicationStatusPhase
DBCOND0050728 (Advanced Endometrial Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05112991Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial CancerTreatment